Role of 3 Tesla Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) for Diagnosis Bladder Cancer Grade and Stage
NCT ID: NCT03138837
Last Updated: 2017-05-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
385 participants
OBSERVATIONAL
2017-05-15
2018-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sensitivity of Multiparametric MRI in Differentiation Between Muscle Invasive and Non-muscle Invasive Urinary Bladder Cancer
NCT05324033
Can VI-RADS/ADC Accurately Stage Bladder Cancer??
NCT04167631
Comprehensive Multiparametric Magnetic Resonance Imaging After Transurethral Resection of Non Muscle-invasive Bladder Tumor; Can it Replace Second Look Biopsy? A Prospective Study
NCT03914001
3 Tesla MRI in Patients With Bladder Cancer
NCT00938145
Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident
NCT03148158
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Magnetic resonance imaging
Diffusion Weighted Magnetic resonance imaging
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Suspected by the out-patient flexible cystoscopy as Non-muscle invasive bladder cancer.
* Patient who will undergo radical cystectomy.
* Patient with history of allergy to iodinated contrast media
Exclusion Criteria
* Patient with any of the following:
1. Any metallic fragment or foreign body
2. Coronary and peripheral artery stents
3. Aortic stent graft
4. Prosthetic heart valves and annuloplasty rings
5. Cardiac pacemaker
6. Implanted cardioverter-defibrillator (ICD)
7. Retained trans venous pacemaker and defibrillator leads
8. Cochlear, otologic, or other ear implant
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abdelwahab Hashem
Urology Msc, Oncology fellow at Urology and Nephrology Center, Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hassan Abol-Enein, MD
Role: STUDY_CHAIR
Urology and Nephrology center
Mohamed AboElghar, MD
Role: STUDY_DIRECTOR
Urology and Nephrology center
Ahmed O. Mosbah, MD
Role: PRINCIPAL_INVESTIGATOR
Urology and Nephrology center
Khaled Sheir, MD
Role: PRINCIPAL_INVESTIGATOR
Urology and Nephrology center
Ahmed Elassmy, MD
Role: PRINCIPAL_INVESTIGATOR
Urology and Nephrology center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Urology and Nephrology Center
Al Mansurah, Aldakahlia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R/17.02.31
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.